National Hospital Organization Kyushu Cancer Center
In research, National Hospital Organization Kyushu Cancer Center stands highest in Medicine (#5,034 of 10,443 worldwide) and Health Sciences (#6,705 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery — Oncology is 20.1× its share of world research.
- World rank, 2022–2025
- #18,247 of 28,054 · #17,570 all time
- Rank in Japan
- #503 of 1,070
- Research works
- 1.6k ▲ 3% vs 2013–17
- Citations
- 28k 17.6 per fractional work
- Top-10% rate
- 8.8% record average 16.5%
- Open access
- 36% world 28%
What is National Hospital Organization Kyushu Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,034 of 10,443 | 9.0% | 134 | #4467 | |
| Health SciencesDomain | #6,705 of 11,982 | 9.2% | 138 | #6143 |
Each strip is that field’s whole ranked pool, with the notch where National Hospital Organization Kyushu Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does National Hospital Organization Kyushu Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 20.1× the share of its output that it takes of world research.
- OncologySubfield · 36.9 works20×
- Pulmonary and Respiratory MedicineSubfield · 29.3 works12×
- SurgerySubfield · 24.1 works6.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Immunology and Microbiology 2.1×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Nursing 1.3×
- Dentistry 0.7×
- Health Professions 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Economics, Econometrics and Finance 0.3×
- Physics and Astronomy 0.3×
- Agricultural and Biological Sciences 0.2×
- Psychology 0.1×
- Neuroscience 0.1×
- Computer Science 0.0×
- Engineering 0.0×
- Social Sciences 0.0×
- Chemistry 0.0×
- Materials Science 0.0×
- Mathematics 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at National Hospital Organization Kyushu Cancer Center?
Ranked on the composite score, Masayuki Furukawa, Masafumi Yamaguchi and Naokuni Uike lead among researchers whose main affiliation is National Hospital Organization Kyushu Cancer Center.
- 1 Masayuki Furukawa Japan · #65,584 worldwide 234 citations · 33 works
- 2 Masafumi Yamaguchi Japan · #85,442 worldwide 247 citations · 39 works
- 3 Naokuni Uike Japan · #138,596 worldwide 100 citations · 34 works
- 4 Yukito Ichinose Japan · #165,125 worldwide 154 citations · 61 works
- 5 Taito Esaki Japan · #188,184 worldwide 175 citations · 54 works
- 6 Mitsuo Kozuru Japan · #202,155 worldwide 80 citations · 23 works
- 7 Rie Sugimoto Japan · #226,173 worldwide 181 citations · 19 works
- 8 Shinichiro Nakamura Japan · #304,099 worldwide 206 citations · 15 works
- 9 Mitsuhiro Takenoyama Japan · #381,232 worldwide 119 citations · 60 works
- 10 Shinji Ohno Japan · #408,611 worldwide 155 citations · 65 works
Which keywords describe research at National Hospital Organization Kyushu Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Neoadjuvant Therapy, Tumor Microenvironment, Prognostic Factors, Radiotherapy and Molecular Characterization.
- Metastatic Breast Cancer
- Chemoradiation
- Metastatic Gastric Cancer
- Cetuximab
- Guidelines
- EGFR Mutations
- Survival
- Genomic Profiling
- Molecular Subtypes
- Prognosis
- Immune Checkpoint Blockade
- Breast Cancer
- Cancer
- Adjuvant Therapy
- Targeted Therapy
- Molecular Characterization
- Radiotherapy
- Epidemiology
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Chemotherapy
- Immunotherapy
- Tumor Microenvironment
- Prognostic Factors
- Inflammation
- Survival Analysis
- Clinical Trials
- Endoscopic Resection
- Metastasis
- Quality of Life
- PD-1 and PD-L1
- Prognostic Markers
- Aging
- Preoperative Chemoradiotherapy
- ALK Inhibitors
- Gastric Cancer
- Neoadjuvant Chemotherapy
- Lymph Node Dissection
- Tumor Staging
- Surgical Management
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy37▲ 32×22 topics
- Clinical Practice Guidelines20▲ 22×10 topics
- Immunotherapy17▲ 15×15 topics
- Neoadjuvant Therapy17▲ 44×5 topics
- Tumor Microenvironment17▲ 23×7 topics
- Epidemiology14▲ 2.2×31 topics
- Prognostic Factors14▲ 19×14 topics
- Radiotherapy13▲ 21×11 topics
- Inflammation13▲ 3.9×24 topics
- Molecular Characterization12▲ 41×5 topics
- Survival Analysis12▲ 26×6 topics
- Targeted Therapy10▲ 29×4 topics
- Clinical Trials10▲ 9.4×10 topics
- Adjuvant Therapy10▲ 48×2 topics
- Endoscopic Resection10▲ 59×2 topics
- Cancer10▲ 4.4×25 topics
- Metastasis9▲ 16×9 topics
- Breast Cancer9▲ 23×10 topics
- Quality of Life8▲ 3.6×14 topics
- Immune Checkpoint Blockade7▲ 40×1 topic
- PD-1 and PD-L17▲ 40×1 topic
- Prognosis7▲ 13×5 topics
- Prognostic Markers7▲ 39×3 topics
- Molecular Subtypes6▲ 46×3 topics
- Aging6▲ 7.1×3 topics
- Genomic Profiling6▲ 36×2 topics
- Preoperative Chemoradiotherapy6▲ 46×2 topics
- Survival6▲ 27×4 topics
- ALK Inhibitors6▲ 57×1 topic
- EGFR Mutations6▲ 57×1 topic
- Gastric Cancer6▲ 32×3 topics
- Guidelines6▲ 7.4×5 topics
- Neoadjuvant Chemotherapy6▲ 41×2 topics
- Cetuximab5▲ 40×2 topics
- Lymph Node Dissection5▲ 56×1 topic
- Metastatic Gastric Cancer5▲ 56×1 topic
- Tumor Staging5▲ 29×2 topics
- Chemoradiation5▲ 49×2 topics
- Surgical Management5▲ 7.7×8 topics
- Metastatic Breast Cancer5▲ 55×2 topics
Which research topics does National Hospital Organization Kyushu Cancer Center publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes and Lung Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 5 works
- 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 5 Bladder and Urothelial Cancer Treatments Surgery 5 works
- 6 Esophageal Cancer Research and Treatment Surgery 4 works
- 7 Nutrition and Health in Aging Physiology 4 works
- 8 Pancreatic and Hepatic Oncology Research Oncology 4 works
- 9 Inflammatory Biomarkers in Disease Prognosis Oncology 4 works
- 10 Colorectal Cancer Treatments and Studies Oncology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Hospital Organization Kyushu Cancer Center's research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Fukuoka
- Kyushu University
- Fukuoka University
- Fukuoka Institute of Technology
- Kyushu University Hospital
- Kyushu Sangyo University
- Fukuoka Dental College
- National Kyushu Medical Center
- Daiichi University of Pharmacy
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.